A Golden Jubilee Editorial - Preventive Medicine's contributions to the science of cervical cancer elimination.

[1]  R. Asgary,et al.  Comparative assessment of test characteristics of cervical cancer screening methods for implementation in low-resource settings. , 2021, Preventive medicine.

[2]  L. Bruni,et al.  Worldwide use of HPV self-sampling for cervical cancer screening. , 2021, Preventive medicine.

[3]  J. Cuzick,et al.  Clinical follow-up practices after cervical cancer screening by co-testing: A population-based study of adherence to U.S. guideline recommendations , 2021, Preventive medicine.

[4]  S. Christy,et al.  Cervical cancer screening in the United States: Challenges and potential solutions for underscreened groups , 2021, Preventive Medicine.

[5]  N. Wentzensen,et al.  Treatment approaches for women with positive cervical screening results in low-and middle-income countries. , 2021, Preventive medicine.

[6]  L. Niccolai,et al.  Monitoring HPV vaccine impact on cervical disease: Status and future directions for the era of cervical cancer elimination. , 2021, Preventive medicine.

[7]  V. Tsu,et al.  National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects , 2021, Preventive medicine.

[8]  A. Hinman,et al.  Elimination of cervical cancer: Lessons learned from polio and earlier eradication programs. , 2021, Preventive medicine.

[9]  M. Goodman,et al.  Achieving cervical cancer elimination among Indigenous women. , 2021, Preventive medicine.

[10]  A. Giuliano,et al.  A world without cervical cancer is within our reach. , 2021, Preventive medicine.

[11]  Maria E Fernandez,et al.  Elimination of cervical cancer in U.S. Hispanic populations: Puerto Rico as a case study. , 2021, Preventive medicine.

[12]  Y. Woo,et al.  Accelerating action on cervical screening in lower- and middle-income countries (LMICs) post COVID-19 era , 2021, Preventive Medicine.

[13]  H. Brandt,et al.  A narrative review of HPV vaccination interventions in rural U.S. communities. , 2020, Preventive medicine.

[14]  L. Bruni,et al.  HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019. , 2020, Preventive medicine.

[15]  K. Sundström,et al.  Cervical screening in high-income countries: the need for quality assurance, adjunct biomarkers and rational adaptation to HPV vaccination. , 2020, Preventive medicine.

[16]  P. Castle,et al.  Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial. , 2020, Preventive medicine.

[17]  S. de Sanjosé,et al.  Introduction of HPV testing for cervical cancer screening in Central America: The Scale-Up project☆ , 2020, Preventive medicine.

[18]  G. Zimet,et al.  Recent changes in cervical cancer screening guidelines: U.S. women's willingness for HPV testing instead of Pap testing. , 2019, Preventive medicine.

[19]  S. Kobrin,et al.  Exacerbating disparities?: Cervical cancer screening and HPV vaccination. , 2019, Preventive medicine.

[20]  P. Sparén,et al.  Mode of HPV vaccination delivery and equity in vaccine uptake: A nationwide cohort study. , 2019, Preventive medicine.

[21]  J. Berkhof,et al.  HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme. , 2019, Preventive medicine.

[22]  P. Castle,et al.  Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in El Salvador. , 2018, Preventive medicine.

[23]  S. de Sanjosé,et al.  Opportunities and challenges for introducing HPV testing for cervical cancer screening in sub-Saharan Africa , 2018, Preventive medicine.

[24]  I. Scarinci,et al.  The challenge of HPV vaccination uptake and opportunities for solutions: Lessons learned from Alabama. , 2018, Preventive medicine.

[25]  M. Saraiya,et al.  Primary HPV testing: U.S. women's awareness and acceptance of an emerging screening modality. , 2017, Preventive medicine.

[26]  M. Schiffman,et al.  Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting. , 2017, Preventive medicine.

[27]  U. Macleod,et al.  Interventions to improve the uptake of cervical cancer screening among lower socioeconomic groups: A systematic review. , 2017, Preventive medicine.